Solange Peters, MD-PhD, PD-MER, is in charge of the thoracic malignancies program in the Department of Oncology of the University of Lausanne, and active in building a translational program in collaboration with the molecular oncology laboratory directed by Prof. D. Hanahan and Prof. E. Meylan as well as the Ludwig Institute. She has been trained in medical oncology and molecular biology in Switzerland and Italy. Her main field of interest is new biomarker discovery and validation in preclinical and clinical settings. She is also heavily involved and interested in developing multimodality trials for locally advanced NSCLC.
She is co-chair of the Swiss lung cancer research group (SAKK), and Scientific Coordinator as well as Chair of the Informatics Committee of the European Thoracic Oncology Platform (ETOP), responsible for communication, trial organization, coordination and related databases since 2012. She is a member and active in educational programs within ESMO and IASLC, and has been an ESMO Faculty member since 2012. She is also a member of the ESMO E-Learning and CME Working Group (ECWG). She has been elected the Swiss national representative of ESMO in 2013. She is IASLC publication committee member and incoming Publication committee chair as well as member of AACR and EORTC. She is the president of the Swiss education organization Forome, dedicated to cancer multidisciplinary professionals.
She was associate editor of Lung Cancer from 2011 to 2012 and became the Deputy Editor of the Journal of Thoracic Oncology (JTO) in 2013. She also acts as associate editor for Frontiers in Pharmacology of Anti-Cancer Drugs and in Thoracic Oncology, and a reviewer for several lung cancer and oncology journals.
She will serve on the Board of Directors for four years, starting at the WCLC in 2013.
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
Journal of Thoracic Oncology
The IASLC’s premier journal, emphasizing a multidisciplinary approach including original research (clinical trials and translational or basic research), reviews and opinion pieces. Visit JTO